PMGC (ELAB) vs Purple Biotech (PPBT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
PMGC is the larger company by market cap ($2.5 million vs $2.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ELAB | PPBT |
|---|---|---|
| Share price | $3.13 | $1.44 |
| Market cap | $2.53M | $2.34M |
| 1-day change | -2.04% | -1.37% |
| EPS (TTM) | $-1,748.36 | $-47.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2,671.20 | $14.10 |
| 52-week low | $2.59 | $1.16 |
| Distance from 52-week high | -99.88% | -89.79% |
| Average volume | 140.44K | 1.28M |
| Shares outstanding | 809.58K | 1.63M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ELAB vs PPBT FAQ
Which is bigger, PMGC or Purple Biotech?
PMGC (ELAB) is larger, with a market capitalization of $2.53M compared with $2.34M for Purple Biotech (PPBT).
Are PMGC and Purple Biotech in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.